latest news releases from the newsroom
Aventine Renewable Energy Holdings, Inc.
Aventine Common Shares to Move to Over-the-Counter Market
PEKIN, Ill., March 23, 2009 (GLOBE NEWSWIRE) -- Aventine Renewable Energy Holdings, Inc (NYSE:AVR), a producer and marketer of fuel-grade ethanol, today announced that its common stock will be quoted on the Over-the-Counter ("OTC") markets beginning Monday, March 30, 2009. The Company expects its stock to continue to be actively traded on the Pink Sheets and is taking the appropriate steps to be quoted on the OTC Bulletin Board ("OTCBB") as well. The move from the New York Stock Exchange to OTC markets is due to the Company's current low market capitalization.
Aastrom Biosciences, Inc.
Aastrom Biosciences Receives Notification That NASDAQ Further Extends Suspension of Certain Continued Listing Requirements
ANN ARBOR, Mich., March 23, 2009 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous adult stem cell treatments for severe chronic cardiovascular diseases, announced that the Company received Issuer Alert #2009-002 from The Nasdaq Stock Market LLC ("NASDAQ"). The Issuer Alert states that, given the continued extraordinary market conditions, NASDAQ has further suspended enforcement of the rules requiring a minimum $1.00 per share closing bid price and a minimum market value of publicly held shares until Monday, July 20, 2009. As a result of NASDAQ further extending the suspension and the balance of 60 days remaining on Aastrom's pending compliance period at the time of the initial suspension, Aastrom now has until September 18, 2009 to regain compliance with the $1.00 minimum closing bid price rule in order to remain listed on the Nasdaq Capital Market.
Elite Pharmaceuticals, Inc.
Elite Announces Signing of Strategic Alliance Agreement; Notification Received From NYSE Amex
NORTHVALE, N.J., March 23, 2009 (GLOBE NEWSWIRE) -- On March 18, 2009, Elite Pharmaceuticals, Inc. ("Elite") (NYSE Amex:ELI) entered into a Strategic Alliance Agreement (the "Alliance Agreement") with Epic Pharma, LLC and Epic Investments, LLC, a wholly-owned subsidiary of Epic Pharma, LLC (collectively "Epic"), pursuant to which Elite will commence a strategic relationship with Epic, a pharmaceutical company that operates a business synergistic to that of Elite in the research and development, manufacturing, sales and marketing of oral immediate and controlled release drug products.
Patient Portal Technologies, Inc.
Patient Portal Technologies, Inc. Files Form 12b-25
BALDWINSVILLE, N.Y., March 23, 2009 (GLOBE NEWSWIRE) -- Patient Portal Technologies, Inc. (OTCBB:PPRG) (Patient Portal) announced today that it has filed Form 12b-25 requesting a fifteen day extension of time to file the Firm 10K for the year ended December 31, 2008.